Publication | Closed Access
Sibutramine Produces Dose‐Related Weight Loss
384
Citations
28
References
1999
Year
Sibutramine administered once daily for 24 weeks in the weight loss phase of treatment for uncomplicated obesity produced dose-related weight loss and was well tolerated. Improvements in serum lipids and uric acid accompany sibutramine-induced weight loss. Most of the adverse events observed on sibutramine are related to its pharmacology, including small mean increases in blood pressure and heart rate.
| Year | Citations | |
|---|---|---|
Page 1
Page 1